[1]Lee BT, Wang Y, Yang A, et al. IgG:IgMratios of liver plasma cells reveal similar phenotypes of primary biliary cholangitis with and without features of autoimmune hepatitis. Clin Gastroenterol Hepatol, 2021, 19(2):397-399. [2]Leung KK, Deeb M, Hirschfield GM.Pathophysiology and management of primary biliary cholangitis. Aliment Pharmacol Ther, 2020, 52(7):1150-1164. [3]Hayashi M, AbeK, Fujita M, et al. Serum Gas6 and Axl as non-invasive biomarkers of advanced histological stage in primary biliary cholangitis. Hepatol Res, 2020, 50(12):1337-1346. [4]Zhou Y, Yang X, Zhang H, et al. The roles of T helper type 17/regulatory T cells in acute rejection after liver transplantation in rats. Transplantation, 2015, 99(6):1126-31. [5]Seitz T, Hellerbrand C. Role of fibroblast growth factor signalling in hepatic fibrosis. Liver Int, 2021, 41(6):1201-1215. [6]Koda Y, Teratani T, Chu PS, et al. CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. Nat Commun, 2021, 12(1):4474. [7]中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和治疗共识(2015年). 中华肝脏病杂志, 2016, 24(1):5-13. [8]Vlachogiannakos J, Binas J, Siakavellas S, et al. Platelet activation and hypercoagulability in patients with early primary biliary cholangitis compared with healthy controls. Ann Gastroenterol, 2021, 34(2):229-234. [9]吴冬秋, 崔丽华, 熊峰, 等. 血清IL-34联合超声弹性成像诊断慢性乙型肝炎患者肝纤维化的效能分析. 实用肝脏病杂志, 2021, 24(1):23-26. [10] John BV, Aitcheson G, Schwartz KB, et al. Male sexis associated with higher rates of liver-related mortality in primary biliary cholangitis and cirrhosis. Hepatology, 2021, 74(2):879-891. [11] Galoosian A, Hanlon C, Zhang J, et al. Clinical updates in primary biliary cholangitis: Trends, epidemiology, diagnostics, and new therapeutic approaches. J Clin Transl Hepatol, 2020, 8(1):49-60. [12] 黄平, 曾霞, 张亚萍, 等. 肝静脉波形分型联合肝脏超声半定量评分对慢性乙型肝炎患者肝纤维化程度评估价值研究. 实用肝脏病杂志, 2022, 25(2):187-190. [13] Kawakami R, Kitagawa Y, Chen KY, et al. Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells. Immunity, 2021, 54(5):947-961 [14] Langhans B, Nischalke HD, Krämer B, et al. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma. Cancer Immunol Immunother, 2019, 68(12):2055-2066. [15] He B, Wu L, Xie W, et al. The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice. BMC Immunol, 2017, 18(1):33. [16] Zhao S, Xu W, Xie YX, et al. CXCR5+ CD4+ T cell subsets and their relationship to immune dysfunction in chronic hepatitis B-associated liver cirrhosis. J Gastroenterol Hepatol, 2020, 35(4):689-695. [17] Crunkhorn S. Targeting TGFβ signalling in T helper cells. Nat Rev Drug Discov, 2020, 19(12):838. [18] Basho K, Zoldan K, Schultheiss M, et al. IL-2 contributes to cirrhosis-associated immune dysfunction by impairing follicular T helper cells in advanced cirrhosis. J Hepatol, 2021, 74(3):649-660. [19] Li X, Su Y, Hua X, et al. Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis. J Transl Med, 2017, 15(1):75. [20] 张辉, 张赓. 外周血中Th17/Treg与慢性乙型肝炎患者乙肝病毒DNA载量的相关性. 广东医学, 2019, 40(16):2345-2349. |